For the past decade there has been a lot of work on drugs called secretase inhibitors , which alter the activity of the enzymes that create amyloid beta - peptide 42 在过去的10年里人们对被称为分泌酶抑制剂的药物进行了大量研究，这种药物可以改变酶类产生淀粉样贝塔-肽42的活动。
Recent evidence shows aromatase inhibitors used alone or in follow - up after two years of tamoxifen therapy demonstrates clear and , in some cases , improved reduction of recurrence risk 近年来证据显示芳香酶抑制剂单独或在三苯氧胺使用两年后来进行治疗乳腺癌可以促进降低复发率。
A surprisingly low seropositivity rate of anti - acetylcholine - receptor antibodies ( 1 / 7 ) and anti - musk ( muscle specific kinase ) antibodies ( 0 / 6 ) were found in these dysphonia mg patients 该诊断在新斯的明（胆碱酯酶抑制剂）试验阳性之前或之后通过纤维喉镜检查和声学分析而被确定。
Now , tamoxifen is still the standard endocrine therapeutic drug or the premenopausal patients , but aromatase inhibitors can bring more benefit for the postmenopausal patients 目前，三苯氧胺对绝经前患者仍是内分泌治疗的标准用药，但对绝经后患者应用芳香化酶抑制剂会有更大的效益。
Huperzine a has been shown to be a powerful selective inhibitor of acetylcholinesterase and has attracted widespread attention because of its unique pharmacological profile and low toxicity 石杉硷甲是一高效、高选择性乙酰胆硷酯酶抑制剂，由于其独特的药理特徵和低毒性，引起了人们的广泛注意。
Huperzine a has been shown to be a powerful selective inhibitor of acetylcholinesterase and has attracted widespread attention because of its unique pharmacological profile and low toxicity 摘要石杉碱甲是一高效、高选择性乙酰胆碱酯酶抑制剂，由于其独特的药理特徵和低毒性，引起了人们的广泛注意。
3 ) the results from y - 32p tracing experiments showed that the level of isotop labeling on pm h + - atpase increased after treatment with meja and fc , respectively . okadaic acid and canthari 3 ）用产p叭h标记质膜h ” ejpase的实验表明，同位素标记结果与蛋白激酶和蛋白磷酸酶抑制剂的实验结果趋势基本一致。
Abstract : huperzine a has been shown to be a powerful selective inhibitor of acetylcholinesterase and has attracted widespread attention because of its unique pharmacological profile and low toxicity 文摘:石杉碱甲是一高效、高选择性乙酰胆碱酯酶抑制剂，由于其独特的药理特征和低毒性,引起了人们的广泛注意。
An nci committee reiewing the study came down against the trial , because of its high cost and because two large studies comparing aromatase inhibitors against placebo are already under way 一位国立癌症研究所委员对这项研究进行评估反对这项试验，因为其带来高成本并且由于两项大宗比较芳香酶抑制剂和安慰剂的研究正在进行。
( 3 ) treatment of naf , a common inhibitor of phosphatasescarried out while light - induced recovery can not prevent dl aggregators from being deaggregated but inhibit p - d1 dephosphorylated and dephosphorylated dl degradated ( 3 )若在弱光恢复前加入蛋白磷酸酯酶抑制剂naf ，聚合物仍然减少，但磷酸化d1蛋白量和d1蛋白总量几乎不变。
